Document:

Exhibit 10.1

 

TRANSACTION SUPPORT AGREEMENT

 

This TRANSACTION
SUPPORT AGREEMENT (this “Agreement”) is entered into as of February 19, 2021, by and among HighCape
Capital Acquisition Corp., a Delaware corporation (“HighCape”), Dr. Jonathan M. Rothberg (“Dr. Rothberg”)
and the undersigned parties listed under Stockholders on the signature page(s) hereto (the “Stockholders”).
Each of HighCape, Dr.  Rothberg and each of the Stockholders are sometimes referred to herein individually as a “Party”
and collectively as the “Parties”. Capitalized terms used but not otherwise defined herein shall have the meanings
ascribed to them in the Business Combination Agreement (defined below).

 

RECITALS

 

WHEREAS, on
February 18, 2021, HighCape, Tenet Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Quantum-Si
Incorporated, a Delaware corporation (the “Company”), entered into that certain Business Combination Agreement
(as amended, supplemented or otherwise modified from time to time in accordance with its terms, the “Business Combination Agreement”)
pursuant to which, among other things, Merger Sub will merge with and into the Company, with the Company as the surviving company
in the merger and, after giving effect to such merger, becoming a wholly-owned Subsidiary of HighCape, in each case, on the terms
and subject to the conditions set forth in the Business Combination Agreement;

 

WHEREAS, Dr. Rothberg
is the Chairman of the Board of Directors of the Company;

 

WHEREAS, each
Stockholder is the record and beneficial owner of the number of shares of Company Series A Preferred Stock set forth opposite
such Stockholder’s name on Schedule A hereto (together with any other Equity Securities of the Company that such
Stockholder acquires record or beneficial ownership of after the date hereof, collectively, the “Subject Company Shares”);

 

WHEREAS, in
consideration for the benefits to be received by Dr. Rothberg and the Stockholders under the terms of the Business Combination
Agreement and as a material inducement to HighCape and the other HighCape Parties agreeing to enter into and consummate the transactions
contemplated by the Business Combination Agreement, the Stockholders and Dr. Rothberg agree to enter into this Agreement
and to be bound by the agreements, covenants and obligations contained in this Agreement; and

 

WHEREAS, the
Parties acknowledge and agree that HighCape and the other HighCape Parties would not have entered into and agreed to consummate
the transactions contemplated by the Business Combination Agreement without the Stockholders and Dr. Rothberg entering into
this Agreement and agreeing to be bound by the agreements, covenants and obligations contained in this Agreement.

 

    

     

    

 

NOW, THEREFORE,
in consideration of the premises and the mutual promises set forth herein and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Parties, each intending to be legally bound, hereby agree as follows:

 

AGREEMENT

 

1.            Company
Stockholder Written Consent and Related Matters.

 

(a)            As
promptly as reasonably practicable (and in any event within two (2) Business Days) following the time at which the Registration
Statement / Proxy Statement is declared effective under the Securities Act, the Stockholders shall duly execute and deliver to
the Company and HighCape the Company Stockholder Written Consent under which they shall irrevocably and unconditionally consent
to the matters, actions and proposals contemplated by Section 5.13(b) (Transaction Support Agreements; Company
Stockholder Approval; PIPE Investor Subscription Agreements) of the Business Combination Agreement. Without limiting the generality
of the first sentence of this Section 1(a), prior to the Closing, the Stockholders shall vote (or cause to be voted)
the Subject Company Shares against and withhold consent with respect to (A) any Company Acquisition Proposal or (B) any
other matter, action or proposal that would reasonably be expected to result in (x) a breach of any of the Company’s
covenants, agreements or obligations under the Business Combination Agreement or (y) any of the conditions to the Closing
set forth in Sections 6.1 or 6.2 of the Business Combination Agreement not being satisfied.

 

(b)            Without
limiting any other rights or remedies of HighCape, each Stockholder hereby irrevocably appoints HighCape or any individual designated
by HighCape as such Stockholder’s agent, attorney-in-fact and proxy (with full power of substitution and resubstituting),
for and in the name, place and stead of such Stockholder, to attend on behalf of such Stockholder any meeting of the Company Stockholders
with respect to the matters described in Section 1(a), to include such Stockholder’s Subject Company Shares
in any computation for purposes of establishing a quorum at any such meeting of the Company Stockholders, to vote (or cause to
be voted) such Stockholder’s Subject Company Shares or consent (or withhold consent) with respect to any of the matters
described in Section 1(a) in connection with any meeting of the Company Stockholders or any action by written
consent by the Company Stockholders (including the Company Stockholder Written Consent), in each case, in the event that such
Stockholder fails to perform or otherwise comply with the covenants, agreements or obligations set forth in Section 1(a).

 

(c)            The
proxy granted by each Stockholder pursuant to Section 1(b) is coupled with an interest sufficient at law to support
an irrevocable proxy and is granted in consideration for HighCape entering into the Business Combination Agreement and agreeing
to consummate the transactions contemplated thereby. The proxy granted by each Stockholder pursuant to Section 1(b) is
also a durable proxy and shall survive the bankruptcy, dissolution, death, incapacity or other inability to act by such Stockholder
and shall revoke any and all prior proxies granted by such Stockholder with respect to its Subject Company Shares. The vote or
consent of the proxyholder in accordance with Section 1(b) and with respect to the matters in Section 1(a) shall
control in the event of any conflict between such vote or consent by the proxyholder of the Subject Company Shares and a vote
or consent by a Stockholder of the Subject Company Shares (or any other Person with the power to vote the Subject Company Shares)
with respect to the matters in Section 1(a). The proxyholder may not exercise the proxy granted pursuant to Section 1(b) on
any matter except those provided in Section 1(a). For the avoidance of doubt, the Stockholder may vote the Subject
Company Shares on all other matters, subject to, for the avoidance of doubt, the other applicable covenants, agreements and obligations
set forth in this Agreement.

 

    2

     

    

 

2.            Other
Covenants and Agreements.

 

(a)            Each
Stockholder shall be bound by and subject to Section 5.3(a) (Confidentiality) and Section 5.4(a) (Public
Announcements) of the Business Combination Agreement to the same extent as such provisions apply to the parties to the Business
Combination Agreement, as if such Stockholder were directly party thereto, and each Stockholder and Dr. Rothberg shall be
bound by and subject to the first sentence of Section 5.6(a) (Exclusive Dealing) and Section 8.18
(Trust Account Waiver) of the Business Combination Agreement to the same extent as such provisions apply to the Company, as
if such Stockholder were directly party thereto. Dr. Rothberg shall, in his capacity has Executive Chairman of the Board
of Directors of the Company, cause to be done such further acts and things as may be reasonably necessary or advisable to cause
the Company to fulfill its obligations under the Business Combination Agreement and consummate the transactions contemplated thereby.

 

(b)            Each
Stockholder and Dr. Rothberg acknowledges and agrees that HighCape and the other HighCape Parties are entering into the Business
Combination Agreement in reliance upon such Stockholder entering into this Agreement and agreeing to be bound by, and perform,
or otherwise comply with, as applicable, the agreements, covenants and obligations contained in this Agreement and but for such
Stockholder and Dr. Rothberg entering into this Agreement and agreeing to be bound by, and perform, or otherwise comply with,
as applicable, the agreements, covenants and obligations contained in this Agreement, HighCape and the other HighCape Parties
would not have entered into or agreed to consummate the transactions contemplated by the Business Combination Agreement.

 

3.            Stockholder
Representations and Warranties. Each of the Stockholders and Dr. Rothberg represents and warrants to HighCape, on behalf
of him or itself, as follows:

 

(a)            Such
Stockholder is a limited liability company, trust or other applicable entity duly organized or formed, as applicable, validly
existing and in good standing (or the equivalent thereof, if applicable, in each case, with respect to the jurisdictions that
recognize the concept of good standing or any equivalent thereof) under the Laws of its jurisdiction of formation or organization
(as applicable).

 

(b)            Such
Stockholder has the requisite limited liability company, trust or other similar power and authority to execute and deliver this
Agreement, to perform its covenants, agreements and obligations hereunder (including, for the avoidance of doubt, those covenants,
agreements and obligations hereunder that relate to the provisions of the Business Combination Agreement), and to consummate the
transactions contemplated hereby. The execution and delivery of this Agreement has been duly authorized by all necessary limited
liability company, trust (or other similar) action on the part of such Stockholder. This Agreement has been duly and validly executed
and delivered by such Stockholder and Dr. Rothberg and constitutes a valid, legal and binding agreement of such Stockholder
and Dr. Rothberg (assuming that this Agreement is duly authorized, executed and delivered by HighCape), enforceable against
such Stockholder and Dr. Rothberg in accordance with its terms (subject to applicable bankruptcy, insolvency, reorganization,
moratorium or other Laws affecting generally the enforcement of creditors’ rights and subject to general principles of equity).

 

    3

     

    

 

(c)            No
consent, approval or authorization of, or designation, declaration or filing with, any Governmental Entity is required on the
part of any Stockholder or Dr. Rothberg with respect to such Stockholder’s or Dr. Rothberg’s execution,
delivery or performance of its covenants, agreements or obligations under this Agreement (including, for the avoidance of doubt,
those covenants, agreements and obligations under this Agreement that relate to the provisions of the Business Combination Agreement)
or the consummation of the transactions contemplated hereby, except for any consents, approvals, authorizations, designations,
declarations, waivers or filings, the absence of which would not adversely affect the ability of the Stockholders or Dr. Rothberg
to perform, or otherwise comply with, any of its covenants, agreements or obligations hereunder in any material respect.

 

(d)            None
of the execution or delivery of this Agreement by the Stockholders and Dr. Rothberg, the performance by the Stockholders
and Dr. Rothberg of any of its covenants, agreements or obligations under this Agreement (including, for the avoidance of
doubt, those covenants, agreements and obligations under this Agreement that relate to the provisions of the Business Combination
Agreement) or the consummation of the transactions contemplated hereby will, directly or indirectly (with or without due notice
or lapse of time or both) (i) result in any breach of any provision of any Stockholder’s Governing Documents, (ii) result
in a violation or breach of, or constitute a default or give rise to any right of termination, Consent, cancellation, amendment,
modification, suspension, revocation or acceleration under, any of the terms, conditions or provisions of any Contract to which
any Stockholder or Dr. Rothberg is a party, (iii) violate, or constitute a breach under, any Order or applicable Law
to which Dr. Rothberg, any Stockholder or any of their respective properties or assets is bound or (iv) result in the
creation of any Lien upon the Subject Company Shares, except, in the case of any of clauses (ii) and (iii) above,
as would not adversely affect the ability of the Stockholders or Dr. Rothberg to perform, or otherwise comply with, any of
its covenants, agreements or obligations hereunder.

 

(e)            Such
Stockholder is the record and beneficial owner of its Subject Company Shares, free and clear of all Liens (other than transfer
restrictions under applicable Securities Law or under the Company Stockholders Agreements). Except for the Equity Securities of
the Company set forth on Schedule A hereto with respect to such Stockholder, together with any other Equity Securities
of the Company that such Stockholder acquires record or beneficial ownership of after the date hereof that is either permitted
pursuant to, or acquired in accordance with, Section 5.1(b)(iv) of the Business Combination Agreement, such Stockholder
does not own, beneficially or of record, any Equity Securities of any Group Company. Except as otherwise expressly contemplated
by the Company Stockholders Agreements and any agreement existing on the date hereof and made available to HighCape or that is
entered into in accordance with the Business Combination Agreement, such Stockholder has no right to acquire any Equity Securities
of any Group Company. Such Stockholder has the sole right to vote (and provide consent in respect of, as applicable) the Subject
Company Shares and, except for this Agreement, the Business Combination Agreement, the Company Stockholders Agreements and any
Contract with respect to a Permitted Transfer, such Stockholder is not party to or bound by (i) any option, warrant, purchase
right, or other Contract that would (either alone or in connection with one or more events, developments or events (including
the satisfaction or waiver of any conditions precedent)) require such Stockholder to Transfer any of its Subject Company Shares
or (ii) any voting trust, proxy or other Contract with respect to the voting or Transfer of any of its Subject Company Shares.

 

    4

     

    

 

(f)            There
is no Proceeding pending or, to Dr. Rothberg’s or such Stockholder’s knowledge, threatened against Dr. Rothberg
or such Stockholder that, if adversely decided or resolved, would reasonably be expected to adversely affect the ability of such
Stockholder to perform, or otherwise comply with, any of its covenants, agreements or obligations under this Agreement in any
material respect.

 

(g)            Dr. Rothberg
and such Stockholder, on its own behalf and on behalf of its Representatives, acknowledges, represents, warrants and agrees that
(i) it has conducted its own independent review and analysis of, and, based thereon, has formed an independent judgment concerning,
the business, assets, condition, operations and prospects of, the HighCape Parties and (ii) it has been furnished with or
given access to such documents and information about the HighCape Parties and their respective businesses and operations as it
and its Representatives have deemed necessary to enable it to make an informed decision with respect to the execution, delivery
and performance of this Agreement, the other Ancillary Documents to which it is or will be a party and the transactions contemplated
hereby and thereby.

 

(h)            In
entering into this Agreement and the other Ancillary Documents to which it is or will be a party, such Stockholder has relied
solely on its own investigation and analysis and the representations and warranties expressly set forth in the Ancillary Documents
to which it is or will be a party and no other representations or warranties of any HighCape Party (including, for the avoidance
of doubt, none of the representations or warranties of any HighCape Party set forth in the Business Combination Agreement or any
other Ancillary Document), any HighCape Non-Party Affiliate or any other Person, either express or implied, and such Stockholder,
on its own behalf and on behalf of its Representatives, acknowledges, represents, warrants and agrees that, except for the representations
and warranties expressly set forth in the Ancillary Documents to which it is or will be a party, none of the HighCape Parties,
any HighCape Non-Party Affiliate or any other Person makes or has made any representation or warranty, either express or implied,
in connection with or related to this Agreement, the Ancillary Documents to which it is or will be a party or the transactions
contemplated hereby or thereby.

 

4.            Transfer
of Subject Securities. Except as expressly contemplated by the Business Combination Agreement, with the prior written consent
of HighCape (such consent to be given or withheld in its sole discretion) or to a Permitted Transferee (as defined below), from
and after the date hereof, each Stockholder agrees not to (a) Transfer any of its Subject Company Shares, (b) enter
into (i) any option, warrant, purchase right, or other Contract that would (either alone or in connection with one or more
events, developments or circumstances (including the satisfaction or waiver of any conditions precedent)) require such Stockholder
to Transfer its Subject Company Shares or (ii) any voting trust, proxy or other Contract with respect to the voting or Transfer
of its Subject Company Shares, or (c) take any actions in furtherance of any of the matters described in the foregoing clauses
(a) or (b). For purposes of this Agreement, “Transfer” means any, direct or indirect, sale,
transfer, assignment, pledge, mortgage, exchange, hypothecation, grant of a security interest in or disposition or encumbrance
of an interest (whether with or without consideration, whether voluntarily or involuntarily or by operation of law or otherwise),
and “Permitted Transferee” means any Person that controls, is controlled by or is under common control with the applicable
Stockholder or Dr. Jonathan M. Rothberg that delivers to HighCape a notice by which he, she or it agrees to be bound by all
the obligations of the applicable Stockholder hereunder with respect to its Subject Company Shares upon a Transfer of such Subject
Company Shares to such Person.

 

    5

     

    

 

5.            Termination.
This Agreement shall automatically terminate, without any notice or other action by any Party, and be void ab initio upon
the earlier of (a) the Effective Time and (b) the termination of the Business Combination Agreement in accordance with
its terms. Upon termination of this Agreement as provided in the immediately preceding sentence, none of the Parties shall have
any further obligations or Liabilities under, or with respect to, this Agreement. Notwithstanding the foregoing or anything to
the contrary in this Agreement, (i) the termination of this Agreement pursuant to Section 5(b) shall not
affect any Liability on the part of any Party for Fraud or a Willful Breach of any covenant or agreement set forth in this Agreement
prior to such termination, (ii) the first sentence of Section 2(a) (solely to the extent that it relates
to Section 5.3(a) (Confidentiality) of the Business Combination Agreement) and the representations and warranties set
forth in Sections 3(g) and (h) shall each survive any termination of this Agreement, (iii) the first
sentence of Section 2(a) (solely to the extent that it relates to Section 5.4(a) (Public Announcements)
of the Business Combination Agreement) shall survive the termination of this Agreement pursuant to Section 5(a) and
(iv) the first sentence of Section 2(a) (solely to the extent that it relates to Section 8.18 (Trust
Account Waiver) of the Business Combination Agreement) shall survive the termination of this Agreement pursuant to Section 5(b).
For purposes of this Section 5, (x) “Willful Breach” means a material breach that is a consequence
of an act undertaken or a failure to act by the breaching Party with the knowledge that the taking of such act or such failure
to act would, or would reasonably be expected to, constitute or result in a breach of this Agreement and (y) “Fraud”
means an act or omission committed by a Party, and requires: (A) a false or incorrect representation or warranty expressly
set forth in this Agreement, (B) with actual knowledge (as opposed to constructive, imputed or implied knowledge) by the
Party making such representation or warranty that such representation or warranty expressly set forth in this Agreement is false
or incorrect, (C) an intention to deceive another Party, to induce him, her or it to enter into this Agreement, (D) another
Party, in justifiable or reasonable reliance upon such false or incorrect representation or warranty expressly set forth in this
Agreement, entering into this Agreement, and (E) such other Party to suffer damage by reason of such reliance. For the avoidance
of doubt, “Fraud” does not include any claim for equitable fraud, promissory fraud, unfair dealings fraud or any torts
(including a claim for fraud or alleged fraud) based on negligence or recklessness.

 

6.            Fiduciary
Duties. Notwithstanding anything in this Agreement to the contrary, (a) no Stockholder makes any agreement or understanding
herein in any capacity other than in such Stockholder’s capacity as a record holder and beneficial owner of its Subject
Company Shares and (b) nothing herein will be construed to limit or affect any action or inaction by any representative or
Affiliate of such Stockholder serving as a member of the board of directors of any Group Company or as an officer, employee or
fiduciary of any Group Company, in each case, acting in such person’s capacity as a director, officer, employee or fiduciary
of such Group Company.

 

7.            No
Recourse. Except for claims pursuant to the Business Combination Agreement or any other Ancillary Document by any party(ies)
thereto against any other party(ies) thereto, each Party agrees that (a) this Agreement may be enforced only against, and
any action for breach of this Agreement may be made only against, the Parties, and no claims of any nature whatsoever (whether
in tort, contract or otherwise) arising under or relating to this Agreement, the negotiation hereof or its subject matter, or
the transactions contemplated hereby shall be asserted against the Company or any Company Non-Party Affiliate (other than any
Stockholder named as a party hereto, on the terms and subject to the conditions set forth herein) or any HighCape Non-Party Affiliate,
and (b) none of the Company, any Company Non-Party Affiliates (other than any Stockholder named as a party hereto, on the
terms and subject to the conditions set forth herein) or any HighCape Non-Party Affiliate shall have any Liability arising out
of or relating to this Agreement, the negotiation hereof or its subject matter, or the transactions contemplated hereby, including
with respect to any claim (whether in tort, contract or otherwise) for breach of this Agreement or in respect of any written or
oral representations made or alleged to be made in connection herewith, as expressly provided herein, or for any actual or alleged
inaccuracies, misstatements or omissions with respect to any information or materials of any kind furnished in connection with
this Agreement, the negotiation hereof or the transactions contemplated hereby.

 

    6

     

    

 

8.            Notices.
All notices, requests, claims, demands and other communications hereunder shall be in writing and shall be given (and shall be
deemed to have been duly given) by delivery in person, by facsimile (having obtained electronic delivery confirmation thereof)
if applicable, e-mail (having obtained electronic delivery confirmation thereof (i.e., an electronic record of the sender that
the email was sent to the intended recipient thereof without an “error” or similar message that such email was not
received by such intended recipient)), or by registered or certified mail (postage prepaid, return receipt requested) (upon receipt
thereof) to the other Parties as follows:

 

If to HighCape, to:

 

c/o HighCape Capital Acquisition Corp.

452 Fifth Avenue, 21st Floor

New York, New York 10018

Attention: Kevin Rakin

E-mail: kevin.rakin@highcape.com

 

with a copy (which shall not constitute notice) to:

 

White & Case LLP

1221 Avenue of the Americas

New York, NY 10020

Attention: Joel L. Rubinstein

E-mail: joel.rubinstein@whitecase.com

 

If to any Stockholder, to:

 

3833 S. Ocean Blvd

Highland Beach, FL 33487

Attention: Michael J. Rothberg

Email: michaelrothberg@mac.com

 

    7

     

    

 

with a copy (which shall not constitute notice) to:

 

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

One Financial Center

Boston, MA 02111

Attention: Michael Fantozzi

E-mail: MLFantozzi@mintz.com

 

If to Dr. Rothberg, to:

 

c/o Quantum-Si Incorporated

530 Old Whitfield Street

Guilford, CT 06437

Attention: Dr. Jonathan M. Rothberg

 

with a copy (which shall not constitute notice) to:

 

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

One Financial Center

Boston, MA 02111

Attention: Michael Fantozzi

E-mail: MLFantozzi@mintz.com

 

or to such other address as the Party to whom notice is given
may have previously furnished to the others in writing in the manner set forth above.

 

9.            Entire
Agreement. This Agreement, the Business Combination Agreement and documents referred to herein and therein constitute the
entire agreement of the Parties with respect to the subject matter of this Agreement, and supersede all prior agreements and undertakings,
both written and oral, among the Parties with respect to the subject matter of this Agreement, except as otherwise expressly provided
in this Agreement.

 

10.            Amendments
and Waivers; Assignment. Any provision of this Agreement may be amended or waived if, and only if, such amendment or waiver
is in writing and signed by Dr. Rothberg, the Stockholders and HighCape. Notwithstanding the foregoing, no failure or delay
by any Party in exercising any right hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof
preclude any other or further exercise of any other right hereunder. Neither this Agreement nor any of the rights, interests or
obligations hereunder shall be assignable by any Stockholder without HighCape’s prior written consent (to be withheld or
given in its sole discretion) except to a Permitted Transferee to which Subject Company Shares are Transferred in accordance with
the terms hereof.

 

11.            Fees
and Expenses. Except as otherwise expressly set forth in the Business Combination Agreement, all fees and expenses incurred
in connection with this Agreement and the transactions contemplated hereby, including the fees and disbursements of counsel, financial
advisors and accountants, shall be paid by the Party incurring such fees or expenses.

 

    8

     

    

 

12.            Remedies.
Except as otherwise expressly provided herein, any and all remedies provided herein will be deemed cumulative with and not exclusive
of any other remedy conferred hereby upon, or available at law or in equity to, such Party, and the exercise by a Party of any
one remedy will not preclude the exercise of any other remedy. The Parties agree that irreparable damage for which monetary damages,
even if available, would not be an adequate remedy, would occur in the event that any Party does not perform its respective obligations
under the provisions of this Agreement in accordance with their specific terms or otherwise breaches such provisions. It is accordingly
agreed that each Party shall be entitled to an injunction or injunctions, specific performance and other equitable relief to prevent
breaches of this Agreement and to enforce specifically the terms and provisions of this Agreement, in each case, without posting
a bond or undertaking and without proof of damages and this being in addition to any other remedy to which they are entitled at
law or in equity. Each Party agrees that it will not oppose the granting of an injunction, specific performance and other equitable
relief when expressly available pursuant to the terms of this Agreement on the basis that the other parties have an adequate remedy
at law or an award of specific performance is not an appropriate remedy for any reason at law or equity.

 

13.            No
Third Party Beneficiaries. This Agreement shall be for the sole benefit of the Parties and their respective successors and
permitted assigns and is not intended, nor shall be construed, to give any Person, other than the Parties and their respective
successors and assigns, any legal or equitable right, benefit or remedy of any nature whatsoever by reason this Agreement. Nothing
in this Agreement, expressed or implied, is intended to or shall constitute the Parties as partners or participants in a joint
venture.

 

14.            Miscellaneous.
Sections 8.1 (Non-Survival), 8.5 (Governing Law), 8.7 (Construction; Interpretation), 8.10 (Severability),
8.11 (Counterparts; Electronic Signatures), 8.15 (Waiver of Jury Trial) and 8.16 (Submission to Jurisdiction)
of the Business Combination Agreement are incorporated herein by reference and shall apply to this Agreement, mutatis mutandis.

 

[Signature page follows]

 

    9

     

    

 

IN WITNESS WHEREOF, the Parties have executed
and delivered this Transaction Support Agreement as of the date first above written.

 

	 	HIGHCAPE
    CAPITAL ACQUISITION CORP.
	 	 	 
	 	 	 
	 	By:	/s/
    Kevin Rakin
	 	Name: 	Kevin Rakin
	 	Title: 	Chief Executive Officer

 

[Signature Page to
Transaction Support Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the Parties have executed
and delivered this Transaction Support Agreement as of the date first above written.

 

	 	STOCKHOLDERS:
	 	 	 
	 	23rd Century
    Capital LLC
	 	 	 
	 	By:	/s/
    Michael J. Rothberg
	 	Name: 	Michael J. Rothberg 
	 	Title:	General Partner
	 	 	 
	 	Jonathan
    M. Rothberg Children’s Trust 2012
	 	 	 
	 	By:	/s/
    Michael J. Rothberg
	 	Name: 	Michael J. Rothberg 
	 	Title:	Trustee

 

 

[Signature Page to Transaction Support
Agreement]

 

    

     

    

 

IN WITNESS WHEREOF, the Parties have executed
and delivered this Transaction Support Agreement as of the date first above written.

 

	 	/s/
    Jonathan M. Rothberg
	 	Dr. Jonathan M. Rothberg

 

[Signature Page to Transaction Support
Agreement]

 

    

     

    

 

SCHEDULE A

 

	Stockholder	Number of Shares of

        Company Series A Preferred
        Stock

	23rd
    Century Capital LLC	22,500,000
	Jonathan
    M. Rothberg Children's Trust 2012	2,500,000Document

Cumulus Media Inc.
Description of 2021 Quarterly Incentive Plan

Awards to executive officers under Cumulus Media Inc.’s (the “Company”) annual executive incentive plan for certain officers of the Company, which operates as a quarterly incentive plan for 2021 (the “2021 QIP”), will be based on the Company achieving budgeted adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) levels, adjusted for any asset sales or purchases. The target cash incentive award opportunity available to each executive officer under the 2021 QIP is calculated as a percentage of each executive officer’s base salary, all in accordance with the terms of each such officer’s existing employment agreement.

Under the 2021 QIP, performance is measured at the end of each quarter, beginning with the quarter ended March 31, 2021, based on year-to-date performance at the end of the respective quarter. If target performance levels for the year-to-date period have been met or exceeded, 12.5% of the total annual target bonus will be awarded following applicable quarter end. If, at the completion of any quarter, target performance levels for the year-to-date period (other than the full year period) have not been met, no payment will be made for that period.

Following the end of the year, actual annual performance will be compared to the pre-established threshold, target and maximum performance goals. If the Company achieves the full-year 2021 target EBITDA goal, each executive officer will be entitled under the 2021 QIP to a total full year payout of 100% of his or her respective 2021 QIP target award opportunity. If the Company achieves the full year threshold EBITDA goal, each executive officer will be entitled under the 2021 QIP to a total payout for the full year equal to 50% (threshold award opportunity) of his or her 2021 QIP target award opportunity, and if the Company meets or exceeds the full year maximum EBITDA goal, each executive officer will be entitled under the 2021 QIP to a total payout of 200% (maximum award opportunity) of his or her 2021 QIP target award opportunity. Actual performance between threshold and target and target and maximum will result in payout amounts determined by linear interpolation. The payout amount calculated for performance over the full-year period will be reduced by payments previously made for the quarterly periods in 2021.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00321-of-00352.parquet"}]]